Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Class of novel indole inhibitors of sPLA2 presented by Lilly

March 9, 2001

Arakis and KS Biomedix establish drug development alliance for arthritis

March 9, 2001

Novel therapeutic approach to rheumatoid arthritis: PPARgamma ligands

March 8, 2001

Roche MMPI examined for population pharmacokinetics in osteoarthritis patients

March 8, 2001

Celltech and Pharmacia to codevelop and copromote CDP-870

March 8, 2001

Inhibitors of cell adhesion designed at Taisho

Feb. 28, 2001

Studies confirm that etoricoxib is one of the most selective COX-2 inhibitors yet reported

Feb. 27, 2001

Iomed enrolls over 300 patients in phase III study for epicondylitis

Feb. 26, 2001

Securiosides selectively cytotoxic to M-CSF-stimulated macrophages

Feb. 23, 2001

Recent patent covers antiinflammatory agents from Ajinomoto

Feb. 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...